According to Latest Study, the global market for Real-time PCR Instruments and Reagents should grow from US$ 4281 million in 2022 to US$ 10800 million by 2029, with a CAGR of 7.5% for the period of 2023-2029.
In Middle East, key players of real-time PCR instruments and reagents include Bioeksen R&D Technologies, Sansure Biotech, Thermo Fisher Scientific, etc. The top three players hold a share about 34%. Egypt is the largest market in Middle East, has around 27% share, followed by Turkey and Saudi Arabia, with about 25% and 18% share, respectively.
In conventional PCR, the amplified DNA product, or amplicon, is detected in an end-point analysis. In real-time PCR, the accumulation of amplification product is measured as the reaction progresses, in real time, with product quantification after each cycle. The main advantage of real-time PCR over PCR is that real-time PCR allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range. Real-time PCR results can either be qualitative (the presence or absence of a sequence) or quantitative (copy number). Quantitative real-time PCR is thus also known as qPCR analysis. In contrast, PCR is at best semiquantitative. Additionally, real-time qPCR data can be evaluated without gelelectrophoresis, resulting in reduced bench time and increased throughput. Finally, because real-time qPCR reactions are run and data are evaluated in a unified, closed-tube qPCR system, opportunities for contamination are reduced and the need for postamplification manipulation is eliminated in qPCR analysis.
This report aims to provide a comprehensive study of the global market for Real-time PCR Instruments and Reagents. Report Highlights:
(1) Global Real-time PCR Instruments and Reagents market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Real-time PCR Instruments and Reagents market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Real-time PCR Instruments and Reagents market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Real-time PCR Instruments and Reagents segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Real-time PCR Instruments and Reagents segment by type and by application and regional segment by type and by application.
(6) Real-time PCR Instruments and Reagents industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Reagent
Instrument
Market segment by application, can be divided into
Infectious Disease
Prenatal and Postnatal Care
Cancer Screening and Treatment
Organ Transplant
Individual Identification
Agriculture
Customs Quarantine
Food Safety
Forensic
Other
Market segment by players, this report covers
Thermo Fisher Scientific
Roche
DaAn Gene
Sansure Biotech
QIAGEN
Bio-Rad
Biosynex
Cepheid
Hangzhou Bloer Technology
Liferiver Bio-Tech
Xi'an Tianlong Science and Technology
Bioperfectus Technologies
BGI Group
Agilent Technologies
Hybribio
Shanghai Biogerm Medical
Shanghai Hongshi Medical Technology
Suzhou Molarray
Merck
Analytik Jena
Takara
Meridian Life Science
Promega Corporation
1 Market Overview
1.1 Product Overview and Scope of Real-time PCR Instruments and Reagents
1.2 Global Real-time PCR Instruments and Reagents Market Size and Forecast
1.3 China Real-time PCR Instruments and Reagents Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Real-time PCR Instruments and Reagents Share in Global Market, 2018-2029
1.4.2 Real-time PCR Instruments and Reagents Market Size: China VS Global, 2018-2029
1.5 Real-time PCR Instruments and Reagents Market Dynamics
1.5.1 Real-time PCR Instruments and Reagents Market Drivers
1.5.2 Real-time PCR Instruments and Reagents Market Restraints
1.5.3 Real-time PCR Instruments and Reagents Industry Trends
1.5.4 Real-time PCR Instruments and Reagents Industry Policy
2 Global Competitive Situation by Company
2.1 Global Real-time PCR Instruments and Reagents Revenue by Company (2018-2023)
2.2 Global Real-time PCR Instruments and Reagents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Real-time PCR Instruments and Reagents Concentration Ratio
2.4 Global Real-time PCR Instruments and Reagents Mergers & Acquisitions, Expansion Plans
2.5 Global Real-time PCR Instruments and Reagents Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Real-time PCR Instruments and Reagents Revenue by Company (2018-2023)
3.2 China Real-time PCR Instruments and Reagents Real-time PCR Instruments and Reagents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Real-time PCR Instruments and Reagents, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Real-time PCR Instruments and Reagents Industry Chain
4.2 Real-time PCR Instruments and Reagents Upstream Analysis
4.3 Real-time PCR Instruments and Reagents Midstream Analysis
4.4 Real-time PCR Instruments and Reagents Downstream Analysis
5 Sights by Type
5.1 Real-time PCR Instruments and Reagents Classification
5.1.1 Reagent
5.1.2 Instrument
5.2 By Type, Global Real-time PCR Instruments and Reagents Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Real-time PCR Instruments and Reagents Revenue, 2018-2029
6 Sights by Application
6.1 Real-time PCR Instruments and Reagents Segment by Application
6.1.1 Infectious Disease
6.1.2 Prenatal and Postnatal Care
6.1.3 Cancer Screening and Treatment
6.1.4 Organ Transplant
6.1.5 Individual Identification
6.1.6 Agriculture
6.1.7 Customs Quarantine
6.1.8 Food Safety
6.1.9 Forensic
6.1.10 Other
6.2 By Application, Global Real-time PCR Instruments and Reagents Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Real-time PCR Instruments and Reagents Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Real-time PCR Instruments and Reagents Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Real-time PCR Instruments and Reagents Market Size, 2018-2029
7.3 North America
7.3.1 North America Real-time PCR Instruments and Reagents Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Real-time PCR Instruments and Reagents Market Size Market Share
7.4 Europe
7.4.1 Europe Real-time PCR Instruments and Reagents Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Real-time PCR Instruments and Reagents Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Real-time PCR Instruments and Reagents Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Real-time PCR Instruments and Reagents Market Size Market Share
7.6 South America
7.6.1 South America Real-time PCR Instruments and Reagents Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Real-time PCR Instruments and Reagents Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Real-time PCR Instruments and Reagents Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.3.2 By Company, U.S. Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.4.2 By Company, Europe Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.5.2 By Company, China Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.5.3 By Type, China Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.6.2 By Company, Japan Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.7.2 By Company, South Korea Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.9.2 By Company, India Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.9.3 By Type, India Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Real-time PCR Instruments and Reagents Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Real-time PCR Instruments and Reagents Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.1.2 Thermo Fisher Scientific Company Profile and Main Business
9.1.3 Thermo Fisher Scientific Real-time PCR Instruments and Reagents Models, Specifications and Application
9.1.4 Thermo Fisher Scientific Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.1.5 Thermo Fisher Scientific Recent Developments
9.2 Roche
9.2.1 Roche Company Information, Head Office, Market Area and Industry Position
9.2.2 Roche Company Profile and Main Business
9.2.3 Roche Real-time PCR Instruments and Reagents Models, Specifications and Application
9.2.4 Roche Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.2.5 Roche Recent Developments
9.3 DaAn Gene
9.3.1 DaAn Gene Company Information, Head Office, Market Area and Industry Position
9.3.2 DaAn Gene Company Profile and Main Business
9.3.3 DaAn Gene Real-time PCR Instruments and Reagents Models, Specifications and Application
9.3.4 DaAn Gene Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.3.5 DaAn Gene Recent Developments
9.4 Sansure Biotech
9.4.1 Sansure Biotech Company Information, Head Office, Market Area and Industry Position
9.4.2 Sansure Biotech Company Profile and Main Business
9.4.3 Sansure Biotech Real-time PCR Instruments and Reagents Models, Specifications and Application
9.4.4 Sansure Biotech Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.4.5 Sansure Biotech Recent Developments
9.5 QIAGEN
9.5.1 QIAGEN Company Information, Head Office, Market Area and Industry Position
9.5.2 QIAGEN Company Profile and Main Business
9.5.3 QIAGEN Real-time PCR Instruments and Reagents Models, Specifications and Application
9.5.4 QIAGEN Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.5.5 QIAGEN Recent Developments
9.6 Bio-Rad
9.6.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
9.6.2 Bio-Rad Company Profile and Main Business
9.6.3 Bio-Rad Real-time PCR Instruments and Reagents Models, Specifications and Application
9.6.4 Bio-Rad Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.6.5 Bio-Rad Recent Developments
9.7 Biosynex
9.7.1 Biosynex Company Information, Head Office, Market Area and Industry Position
9.7.2 Biosynex Company Profile and Main Business
9.7.3 Biosynex Real-time PCR Instruments and Reagents Models, Specifications and Application
9.7.4 Biosynex Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.7.5 Biosynex Recent Developments
9.8 Cepheid
9.8.1 Cepheid Company Information, Head Office, Market Area and Industry Position
9.8.2 Cepheid Company Profile and Main Business
9.8.3 Cepheid Real-time PCR Instruments and Reagents Models, Specifications and Application
9.8.4 Cepheid Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.8.5 Cepheid Recent Developments
9.9 Hangzhou Bloer Technology
9.9.1 Hangzhou Bloer Technology Company Information, Head Office, Market Area and Industry Position
9.9.2 Hangzhou Bloer Technology Company Profile and Main Business
9.9.3 Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Models, Specifications and Application
9.9.4 Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.9.5 Hangzhou Bloer Technology Recent Developments
9.10 Liferiver Bio-Tech
9.10.1 Liferiver Bio-Tech Company Information, Head Office, Market Area and Industry Position
9.10.2 Liferiver Bio-Tech Company Profile and Main Business
9.10.3 Liferiver Bio-Tech Real-time PCR Instruments and Reagents Models, Specifications and Application
9.10.4 Liferiver Bio-Tech Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.10.5 Liferiver Bio-Tech Recent Developments
9.11 Xi'an Tianlong Science and Technology
9.11.1 Xi'an Tianlong Science and Technology Company Information, Head Office, Market Area and Industry Position
9.11.2 Xi'an Tianlong Science and Technology Company Profile and Main Business
9.11.3 Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Models, Specifications and Application
9.11.4 Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.11.5 Xi'an Tianlong Science and Technology Recent Developments
9.12 Bioperfectus Technologies
9.12.1 Bioperfectus Technologies Company Information, Head Office, Market Area and Industry Position
9.12.2 Bioperfectus Technologies Company Profile and Main Business
9.12.3 Bioperfectus Technologies Real-time PCR Instruments and Reagents Models, Specifications and Application
9.12.4 Bioperfectus Technologies Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.12.5 Bioperfectus Technologies Recent Developments
9.13 BGI Group
9.13.1 BGI Group Company Information, Head Office, Market Area and Industry Position
9.13.2 BGI Group Company Profile and Main Business
9.13.3 BGI Group Real-time PCR Instruments and Reagents Models, Specifications and Application
9.13.4 BGI Group Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.13.5 BGI Group Recent Developments
9.14 Agilent Technologies
9.14.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
9.14.2 Agilent Technologies Company Profile and Main Business
9.14.3 Agilent Technologies Real-time PCR Instruments and Reagents Models, Specifications and Application
9.14.4 Agilent Technologies Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.14.5 Agilent Technologies Recent Developments
9.15 Hybribio
9.15.1 Hybribio Company Information, Head Office, Market Area and Industry Position
9.15.2 Hybribio Company Profile and Main Business
9.15.3 Hybribio Real-time PCR Instruments and Reagents Models, Specifications and Application
9.15.4 Hybribio Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.15.5 Hybribio Recent Developments
9.16 Shanghai Biogerm Medical
9.16.1 Shanghai Biogerm Medical Company Information, Head Office, Market Area and Industry Position
9.16.2 Shanghai Biogerm Medical Company Profile and Main Business
9.16.3 Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Models, Specifications and Application
9.16.4 Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.16.5 Shanghai Biogerm Medical Recent Developments
9.17 Shanghai Hongshi Medical Technology
9.17.1 Shanghai Hongshi Medical Technology Company Information, Head Office, Market Area and Industry Position
9.17.2 Shanghai Hongshi Medical Technology Company Profile and Main Business
9.17.3 Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Models, Specifications and Application
9.17.4 Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.17.5 Shanghai Hongshi Medical Technology Recent Developments
9.18 Suzhou Molarray
9.18.1 Suzhou Molarray Company Information, Head Office, Market Area and Industry Position
9.18.2 Suzhou Molarray Company Profile and Main Business
9.18.3 Suzhou Molarray Real-time PCR Instruments and Reagents Models, Specifications and Application
9.18.4 Suzhou Molarray Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.18.5 Suzhou Molarray Recent Developments
9.19 Merck
9.19.1 Merck Company Information, Head Office, Market Area and Industry Position
9.19.2 Merck Company Profile and Main Business
9.19.3 Merck Real-time PCR Instruments and Reagents Models, Specifications and Application
9.19.4 Merck Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.19.5 Merck Recent Developments
9.20 Analytik Jena
9.20.1 Analytik Jena Company Information, Head Office, Market Area and Industry Position
9.20.2 Analytik Jena Company Profile and Main Business
9.20.3 Analytik Jena Real-time PCR Instruments and Reagents Models, Specifications and Application
9.20.4 Analytik Jena Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.20.5 Analytik Jena Recent Developments
9.21 Takara
9.21.1 Takara Company Information, Head Office, Market Area and Industry Position
9.21.2 Takara Company Profile and Main Business
9.21.3 Takara Real-time PCR Instruments and Reagents Models, Specifications and Application
9.21.4 Takara Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.21.5 Takara Recent Developments
9.22 Meridian Life Science
9.22.1 Meridian Life Science Company Information, Head Office, Market Area and Industry Position
9.22.2 Meridian Life Science Company Profile and Main Business
9.22.3 Meridian Life Science Real-time PCR Instruments and Reagents Models, Specifications and Application
9.22.4 Meridian Life Science Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.22.5 Meridian Life Science Recent Developments
9.23 Promega Corporation
9.23.1 Promega Corporation Company Information, Head Office, Market Area and Industry Position
9.23.2 Promega Corporation Company Profile and Main Business
9.23.3 Promega Corporation Real-time PCR Instruments and Reagents Models, Specifications and Application
9.23.4 Promega Corporation Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
9.23.5 Promega Corporation Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Real-time PCR Instruments and Reagents Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Real-time PCR Instruments and Reagents Market Restraints
Table 3. Real-time PCR Instruments and Reagents Market Trends
Table 4. Real-time PCR Instruments and Reagents Industry Policy
Table 5. Global Real-time PCR Instruments and Reagents Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Real-time PCR Instruments and Reagents Revenue Market Share by Company (2018-2023)
Table 7. Global Real-time PCR Instruments and Reagents Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Real-time PCR Instruments and Reagents Mergers & Acquisitions, Expansion Plans
Table 9. Global Real-time PCR Instruments and Reagents Manufacturers Product Type
Table 10. China Real-time PCR Instruments and Reagents Revenue by Company (2018-2023) & (US$ million)
Table 11. China Real-time PCR Instruments and Reagents Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Real-time PCR Instruments and Reagents Upstream (Raw Materials)
Table 13. Global Real-time PCR Instruments and Reagents Typical Customers
Table 14. Real-time PCR Instruments and Reagents Typical Distributors
Table 15. By Type, Global Real-time PCR Instruments and Reagents Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Real-time PCR Instruments and Reagents Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Real-time PCR Instruments and Reagents Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Real-time PCR Instruments and Reagents Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Real-time PCR Instruments and Reagents Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Real-time PCR Instruments and Reagents Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2029
Table 22. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 23. Thermo Fisher Scientific Company Profile and Main Business
Table 24. Thermo Fisher Scientific Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 25. Thermo Fisher Scientific Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Roche Company Information, Head Office, Market Area and Industry Position
Table 28. Roche Company Profile and Main Business
Table 29. Roche Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 30. Roche Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 31. Roche Recent Developments
Table 32. DaAn Gene Company Information, Head Office, Market Area and Industry Position
Table 33. DaAn Gene Company Profile and Main Business
Table 34. DaAn Gene Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 35. DaAn Gene Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 36. DaAn Gene Recent Developments
Table 37. Sansure Biotech Company Information, Head Office, Market Area and Industry Position
Table 38. Sansure Biotech Company Profile and Main Business
Table 39. Sansure Biotech Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 40. Sansure Biotech Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 41. Sansure Biotech Recent Developments
Table 42. QIAGEN Company Information, Head Office, Market Area and Industry Position
Table 43. QIAGEN Company Profile and Main Business
Table 44. QIAGEN Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 45. QIAGEN Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 46. QIAGEN Recent Developments
Table 47. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 48. Bio-Rad Company Profile and Main Business
Table 49. Bio-Rad Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 50. Bio-Rad Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 51. Bio-Rad Recent Developments
Table 52. Biosynex Company Information, Head Office, Market Area and Industry Position
Table 53. Biosynex Company Profile and Main Business
Table 54. Biosynex Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 55. Biosynex Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 56. Biosynex Recent Developments
Table 57. Cepheid Company Information, Head Office, Market Area and Industry Position
Table 58. Cepheid Company Profile and Main Business
Table 59. Cepheid Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 60. Cepheid Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 61. Cepheid Recent Developments
Table 62. Hangzhou Bloer Technology Company Information, Head Office, Market Area and Industry Position
Table 63. Hangzhou Bloer Technology Company Profile and Main Business
Table 64. Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 65. Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 66. Hangzhou Bloer Technology Recent Developments
Table 67. Liferiver Bio-Tech Company Information, Head Office, Market Area and Industry Position
Table 68. Liferiver Bio-Tech Company Profile and Main Business
Table 69. Liferiver Bio-Tech Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 70. Liferiver Bio-Tech Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 71. Liferiver Bio-Tech Recent Developments
Table 72. Xi'an Tianlong Science and Technology Company Information, Head Office, Market Area and Industry Position
Table 73. Xi'an Tianlong Science and Technology Company Profile and Main Business
Table 74. Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 75. Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 76. Xi'an Tianlong Science and Technology Recent Developments
Table 77. Bioperfectus Technologies Company Information, Head Office, Market Area and Industry Position
Table 78. Bioperfectus Technologies Company Profile and Main Business
Table 79. Bioperfectus Technologies Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 80. Bioperfectus Technologies Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 81. Bioperfectus Technologies Recent Developments
Table 82. BGI Group Company Information, Head Office, Market Area and Industry Position
Table 83. BGI Group Company Profile and Main Business
Table 84. BGI Group Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 85. BGI Group Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 86. BGI Group Recent Developments
Table 87. Agilent Technologies Company Information, Head Office, Market Area and Industry Position
Table 88. Agilent Technologies Company Profile and Main Business
Table 89. Agilent Technologies Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 90. Agilent Technologies Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 91. Agilent Technologies Recent Developments
Table 92. Hybribio Company Information, Head Office, Market Area and Industry Position
Table 93. Hybribio Company Profile and Main Business
Table 94. Hybribio Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 95. Hybribio Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 96. Hybribio Recent Developments
Table 97. Shanghai Biogerm Medical Company Information, Head Office, Market Area and Industry Position
Table 98. Shanghai Biogerm Medical Company Profile and Main Business
Table 99. Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 100. Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 101. Shanghai Biogerm Medical Recent Developments
Table 102. Shanghai Hongshi Medical Technology Company Information, Head Office, Market Area and Industry Position
Table 103. Shanghai Hongshi Medical Technology Company Profile and Main Business
Table 104. Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 105. Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 106. Shanghai Hongshi Medical Technology Recent Developments
Table 107. Suzhou Molarray Company Information, Head Office, Market Area and Industry Position
Table 108. Suzhou Molarray Company Profile and Main Business
Table 109. Suzhou Molarray Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 110. Suzhou Molarray Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 111. Suzhou Molarray Recent Developments
Table 112. Merck Company Information, Head Office, Market Area and Industry Position
Table 113. Merck Company Profile and Main Business
Table 114. Merck Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 115. Merck Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 116. Merck Recent Developments
Table 117. Analytik Jena Company Information, Head Office, Market Area and Industry Position
Table 118. Analytik Jena Company Profile and Main Business
Table 119. Analytik Jena Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 120. Analytik Jena Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 121. Analytik Jena Recent Developments
Table 122. Takara Company Information, Head Office, Market Area and Industry Position
Table 123. Takara Company Profile and Main Business
Table 124. Takara Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 125. Takara Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 126. Takara Recent Developments
Table 127. Meridian Life Science Company Information, Head Office, Market Area and Industry Position
Table 128. Meridian Life Science Company Profile and Main Business
Table 129. Meridian Life Science Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 130. Meridian Life Science Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 131. Meridian Life Science Recent Developments
Table 132. Promega Corporation Company Information, Head Office, Market Area and Industry Position
Table 133. Promega Corporation Company Profile and Main Business
Table 134. Promega Corporation Real-time PCR Instruments and Reagents Models, Specifications and Application
Table 135. Promega Corporation Real-time PCR Instruments and Reagents Revenue and Gross Margin, 2018-2023
Table 136. Promega Corporation Recent Developments
List of Figure
Figure 1. Real-time PCR Instruments and Reagents Picture
Figure 2. Global Real-time PCR Instruments and Reagents Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Real-time PCR Instruments and Reagents Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Real-time PCR Instruments and Reagents Market Share of Global
Figure 5. Global Real-time PCR Instruments and Reagents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Real-time PCR Instruments and Reagents Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Real-time PCR Instruments and Reagents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Real-time PCR Instruments and Reagents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Real-time PCR Instruments and Reagents Industry Chain
Figure 10. Reagent
Figure 11. Instrument
Figure 12. By Type, Global Real-time PCR Instruments and Reagents Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2029
Figure 14. Infectious Disease
Figure 15. Prenatal and Postnatal Care
Figure 16. Cancer Screening and Treatment
Figure 17. Organ Transplant
Figure 18. Individual Identification
Figure 19. Agriculture
Figure 20. Customs Quarantine
Figure 21. Food Safety
Figure 22. Forensic
Figure 23. Other
Figure 24. By Application, Global Real-time PCR Instruments and Reagents Revenue, 2018-2029, US$ Million
Figure 25. By Application, Global Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2029
Figure 26. By Region, Global Real-time PCR Instruments and Reagents Revenue Market Share, 2018-2029
Figure 27. North America Rea
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|